In light of this consideration, it is perhaps no small coincidence that leading clinical CF drugs such as Trikafta (20, 21) contain combinations of stabilizing pharmacochaperones that bind distinct pockets in order to achieve greater rescue of misfolded CFTR variants (22). Here, CFTR is linked to cystic fibrosis.